TERT and cancer: First, we analysed two telomerase-positive tumors (HCT116 and SK-MEL28), normally expressing TERT and presenting telomerase activity; then, we induced TERT expression in two TERT-lacking cancer cell lines (U2OS and SAOS) (S1A Fig), characterized by the alternative mechanism of telomere lengthening (ALT).